Zobrazeno 1 - 10
of 208
pro vyhledávání: '"EUSTAR collaborators*"'
Autor:
Anja Wyss, Suzana Jordan, Nicole Graf, Patricia E. Carreira, Jörg Distler, Marco Matucci Cerinic, Elise Siegert, Jörg Henes, Elisabetta Zanatta, Valeria Riccieri, Marie-Elise Truchetet, Fahrettin Oksel, Mengtao Li, Eugene J. Kucharz, Kilian Eyerich, Francesco Del Galdo, Madelon C. Vonk, Anna-Maria Hoffman Vold, Armando Gabrielli, Oliver Distler, EUSTAR collaborators
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-10 (2024)
Abstract Objective Patients with diffuse cutaneous systemic sclerosis (dcSSc) frequently show spontaneous improvement of skin fibrosis. Our aim was to examine whether an improvement in skin fibrosis predicts lower likelihood of visceral organ progres
Externí odkaz:
https://doaj.org/article/6ecdc151f90c4492a981c9fd58d1e522
Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort
Autor:
Marco Matucci-Cerinic, Tom W J Huizinga, Paolo Airo, Jeska De Vries-Bouwstra, Elisabetta Zanatta, László Czirják, Piotr Wiland, Tatsuya Atsumi, Suzanne Cannegieter, Saad Ahmed, Gabriella Szücs, Francesco Ursini, Ina Koetter, Alexandra Balbir Gurman, Joerg C Henes, Jacopo Ciaffi, Sophie I E Liem, Eva M Hoekstra, EUSTAR Collaborators
Publikováno v:
RMD Open, Vol 10, Iss 2 (2024)
Objectives To untangle the association between smoking and systemic sclerosis (SSc).Methods In the European Scleroderma Trials and Research cohort, the autoantibody status was compared between ever-smokers and never-smokers. Time until disease progre
Externí odkaz:
https://doaj.org/article/f2427f3bbc774c75a3024c3f2b0e53c7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gemma Lepri, Cosimo Bruni, Lorenzo Tofani, Alberto Moggi-Pignone, Martina Orlandi, Sara Tomassetti, Michael Hughes, Francesco Del Galdo, Rosaria Irace, Oliver Distler, Valeria Riccieri, Yannick Allanore, Ana Maria Gheorghiu, Elise Siegert, Jeska De Vries-Bouwstra, Eric Hachulla, Mohammed Tikly, Nemanja Damjanov, Francois Spertini, Luc Mouthon, Anna-Maria Hoffmann-Vold, Armando Gabrielli, Serena Guiducci, Marco Matucci-Cerinic, Daniel Furst, Silvia Bellando-Randone, EUSTAR Collaborators
Publikováno v:
Diagnostics, Vol 14, Iss 3, p 295 (2024)
Background and Objectives: In SSc, ILD is a major cause of morbidity and mortality. We aimed to investigate the performance of DLCO (diffusing capacity of lung carbon monoxide) and FVC (forced vital capacity) delta change (Δ) and baseline values in
Externí odkaz:
https://doaj.org/article/4324efc6c11f4af5be29e4dde48db84d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mongin D; Geneva University Hospitals, Geneva, Switzerland., Matucci-Cerinic M; IRCCS San Raffaele Scientific Institute, Milan, Italy, IRCCS San Raffaele Hospital, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Walker UA; University Hospital Basel, Basel, Switzerland., Distler O; University Hospital Zurich, Zurich, Switzerland., Becvar R; University, Prague, Czech Republic., Siegert E; Charité University Hospital, Berlin, Germany., Ananyeva LP; V.A. Nasonova Research Institute of Rheumatology Russian Federation, Moskow, Russia., Smith V; Ghent University, Ghent, Belgium; Ghent University Hospital, Ghent, Belgium; VIB Inflammation Research Center (IRC), Ghent, Belgium., Alegre-Sancho JJ; Hospital Universitario Dr. Peset, Valencia, Spain., Yavuz S; Istanbul Bilim University, Altunizade-Istanbul, Turkey., Limonta M; ASST Papa Giovanni XXIII, Begamo, Italy., Riemekasten G; Klinik Für Rheumatologie Und Klinische Immunologie, Universitätsklinikum Schleswig-Holstein, Lübeck, Germany., Rezus E; Grigore T. Popa University of Medicine and Pharmacy Iasi, Rehabilitation Hospital Iasi, Romania., Vonk M; Radboud University Medical Center, Nijmegen, The Netherlands., Truchetet ME; National Reference Center for Systemic Autoimmune Rare Diseases, Bordeaux University Hospital, Hôpital Pellegrin, place Amélie-Raba-Léon, Bordeaux, France., Del Galdo F; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom., Courvoisier DS; Geneva University Hospitals, Geneva, Switzerland., Iudici M; Geneva University Hospitals, Geneva, Switzerland.
Publikováno v:
Arthritis care & research [Arthritis Care Res (Hoboken)] 2024 Nov 14. Date of Electronic Publication: 2024 Nov 14.
Autor:
Colalillo A; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy., Hachulla E; University of Lille, INSERM, CHU Lille, Department of Internal Medicine and Clinical Immunology, Hôpital Claude Huriez, CERAINOM, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France., Pellicano C; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy., Smith V; Department of Internal Medicine and Department of Rheumatology, Ghent University Hospital, Ghent, Belgium; Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Center (IRC), Ghent, Belgium., Bergmann C; Department of Internal Medicine, University Hospital Erlangen, Erlangen, Germany., Riemekasten G; Department of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, Germany., Zanatta E; Rheumatology Unit, Padova University Hospital, Padua, Italy., Henes J; Center for Interdisciplinary Rheumatology, Auto-inflammatory Diseases and Internal Medicine, University Hospital Tübingen, Tübingen, Germany., Launay D; University of Lille, INSERM, CHU Lille, Department of Internal Medicine and Clinical Immunology, Hôpital Claude Huriez, CERAINOM, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France., Marcoccia A; Centro di Riferimento Interdisciplinare, Interdipartimentale per la Diagnosi Precoce della Sclerodermia (CRIIS), Sandro Pertini Hospital, Rome, Italy., Gheorghiu AM; Carol Davila University on Medicine and Pharmacy, Internal Medicine and Rheumatology Department, Cantacuzino Hospital, Bucharest, Romania., Truchetet ME; Department of Rheumatology, CHU de Bordeaux, Bordeaux, France., Iannone F; Rheumatology Unit, University of Bari, Bari, Italy., Simeón Aznar CP; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, Barcelona, Spain., Oliveira S; Systemic Immunomediated Diseases Unit, Department of Medicine, Amadora, Portugal., Vonk M; Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands., Del Galdo F; Leeds Raynaud's and Scleroderma Program, NIHR Biomedical Research Centre Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, England., Rosato E; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy. Electronic address: edoardo.rosato@uniroma1.it.
Publikováno v:
Chest [Chest] 2024 Oct; Vol. 166 (4), pp. 837-844. Date of Electronic Publication: 2024 Jun 06.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yannick Allanore, Sylvie Bozzi, Augustin Terlinden, Doerte Huscher, Caroline Amand, Christina Soubrane, Elise Siegert, László Czirják, Patricia E. Carreira, Eric Hachulla, Elisabetta Zanatta, Mengtao Li, Paolo Airò, Fabian A. Mendoza, Edoardo Rosato, Oliver Distler, on behalf of the EUSTAR Collaborators
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-11 (2020)
Abstract Background Patients with diffuse cutaneous systemic sclerosis (dcSSc) have a poor prognosis. The importance of monitoring subjective measures of functioning and disability, such as the Health Assessment Questionnaire-Disability Index (HAQ-DI
Externí odkaz:
https://doaj.org/article/b0740c2493be40d498a6dc3efcc2210a